SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-10-196692
Filing Date
2010-08-25
Accepted
2010-08-25 14:30:37
Documents
3
Group Members
CLARUS VENTURES II GP, L.P.CLARUS VENTURES II, LLCDENNIS HENNERJEFFREY LEIDENKURT WHEELERMICHAEL STEINMETZNICHOLAS GALAKATOSNICHOLAS SIMONROBERT LIPTAK

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D AMENDMENT NO. 2 dsc13da.htm SC 13D/A 176569
2 AGREEMENT REGARDING FILING OF JOINT SCHEDULE 13D dex1.htm EX-1 10868
3 POWER OF ATTORNEY DATED AS OF APRIL 11, 2008 dex2.htm EX-2 7644
  Complete submission text file 0001193125-10-196692.txt   197275
Mailing Address 300 GEORGE STREET NEW HAVEN CT 06511
Business Address 300 GEORGE STREET NEW HAVEN CT 06511 203-624-7000
ACHILLION PHARMACEUTICALS INC (Subject) CIK: 0001070336 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-82163 | Film No.: 101037438
SIC: 2834 Pharmaceutical Preparations

Mailing Address 101 MAIN STREET SUITE 1210 CAMBRIDGE MA 02142
Business Address 101 MAIN STREET SUITE 1210 CAMBRIDGE MA 02142 617-949-2200
Clarus Lifesciences II, L.P. (Filed by) CIK: 0001431443 (see all company filings)

IRS No.: 261856183 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A